Point Out Caveats With Direct-to-Consumer Meds

More drug companies and third-party platforms are selling Rx meds directly to patients...such as Eliquis, Wegovy, Xofluza, and Zepbound.

These direct-to-consumer (DTC) Rx programs appeal to patients by offering discounted and transparent pricing, convenience, privacy, etc.

But point out that not all DTC programs translate into big savings...and there can be other caveats. Help weigh pros and cons.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote